Xuefei Shi
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 15
- Molecular Biology top 5%
- RNA modifications and cancer 14
- RNA Research and Splicing 10
- Circular RNAs in diseases 3
-
- Lung Cancer Research Studies 6
-
- Neuroendocrine Tumor Research Advances 2
-
- Lung Cancer Treatments and Mutations 4
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Partner nations
- ChinaUnited States
In The Last Decade
Xuefei Shi
33 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 2.1k
- Molecular Biology 2.0k
- Oncology 193
- Epidemiology 203
- Pulmonary and Respiratory Medicine 171
Countries citing papers authored by Xuefei Shi
This map shows the geographic impact of Xuefei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefei Shi more than expected).
Fields of papers citing papers by Xuefei Shi
This network shows the impact of papers produced by Xuefei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefei Shi. The network helps show where Xuefei Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuefei Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 9 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 16 | |
| 7 | 2020 | 3 | |
| 8 | 2019 | 35 | |
| 9 | 2019 | 109 | |
| 10 | 2016 | 77 | |
| 11 | 2016 | 100 | |
| 12 | 2015 | 32 | |
| 13 | 2015 | 17 | |
| 14 | 2015 | 148 | |
| 15 | 2015 | 78 | |
| 16 | 2014 | 15 | |
| 17 | 2014 | 30 | |
| 18 | 2014 | 18 | |
| 19 | 2014 | 41 | |
| 20 | Long non-coding RNAs: A new frontier in the study of human diseasesbreakdown → | 2013 | 979 |
About Xuefei Shi
Xuefei Shi is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 34 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (14 papers), RNA Research and Splicing (10 papers), Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (4 papers), Circular RNAs in diseases (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (2.0k citations) and Oncology (193 citations). Xuefei Shi has collaborated with scholars based in China and United States. Frequent co-authors include Yong Song, Yingshui Yao, Ming Sun, Hongbing Liu, Hongbing Liu, Ying Wu, Qingqing Zhu, Fangfang Chen, Yong Song and Rong Kong. Their work appears in journals such as PLoS ONE, Scientific Reports and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.